Assessment of Safety and Efficacy of Insulin NPH [insulin suspension isophane] Compared to a New Insulin Formulation on Glycaemic Control in Subjects With Type 2 Diabetes.

Trial Profile

Assessment of Safety and Efficacy of Insulin NPH [insulin suspension isophane] Compared to a New Insulin Formulation on Glycaemic Control in Subjects With Type 2 Diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 May 2015

At a glance

  • Drugs EX 1000 (Primary) ; Insulin; Insulin suspension isophane
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 14 Oct 2010 Actual end date changed from Feb 2009 to Mar 2009 as reported by ClinicalTrials.gov.
    • 14 Oct 2010 Actual initiation date changed from Apr 2008 to Feb 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top